Literature DB >> 11328356

Behavioural profiling of a murine Charcot-Marie-Tooth disease type 1A model.

J C Norreel1, M Jamon, G Riviere, E Passage, M Fontes, F Clarac.   

Abstract

Different features of motor behaviour were studied on a transgenic mouse model of Charcot-Marie-Tooth's disease (CMT). Mutants with 4 or 7 copies of the human PMP22 gene leading to a phenotype significantly close to CMT's disease type 1A were compared with control animals. The aim of the study was to validate this transgenic model and to characterise the impairments occurring in the various lines. Three main types of analysis were performed in 2-month-old mice without any peculiar visible deficit: (i) a study of standardised clinical tests (SHIRPA protocol) demonstrated that only a few motor deficits were expressed; (ii) a measurement of general spontaneous activity by means of a commercial video-tracking system was performed and revealed that the main spontaneous activities were identical in the three lines with, however, some slight localised modifications; and, (iii) by contrast, the three lines respond very differently to the footprints, grip strength, splay test and rotarod test. Even in lines with a significantly limited copy number of the transgene, we observed and quantified impairments. In conclusion, mutants of CMT1A seem to be a very pertinent model of this human pathology and will certainly be useful for therapeutic procedures and for theoretical studies on this disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328356     DOI: 10.1046/j.0953-816x.2001.01535.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  12 in total

1.  Implementation of the modified-SHIRPA protocol for screening of dominant phenotypes in a large-scale ENU mutagenesis program.

Authors:  Hiroshi Masuya; Maki Inoue; Yumiko Wada; Aya Shimizu; Junko Nagano; Akiko Kawai; Ayako Inoue; Tomoko Kagami; Taeko Hirayama; Ayako Yamaga; Hideki Kaneda; Kimio Kobayashi; Osamu Minowa; Ikuo Miura; Yoichi Gondo; Tetsuo Noda; Shigeharu Wakana; Toshihiko Shiroishi
Journal:  Mamm Genome       Date:  2005-11-11       Impact factor: 2.957

2.  PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.

Authors:  Hien Tran Zhao; Sagar Damle; Karli Ikeda-Lee; Steven Kuntz; Jian Li; Apoorva Mohan; Aneeza Kim; Gene Hung; Mark A Scheideler; Steven S Scherer; John Svaren; Eric E Swayze; Holly B Kordasiewicz
Journal:  J Clin Invest       Date:  2017-12-04       Impact factor: 14.808

Review 3.  Molecular genetics of autosomal-recessive axonal Charcot-Marie-Tooth neuropathies.

Authors:  Rafaëlle Bernard; Annachiara De Sandre-Giovannoli; Valérie Delague; Nicolas Lévy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 4.  Animal models of Charcot-Marie-Tooth disease type 1A.

Authors:  M W Sereda; K-A Nave
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse.

Authors:  Annachiara De Sandre-Giovannoli; Malika Chaouch; Serguei Kozlov; Jean-Michel Vallat; Meriem Tazir; Nadia Kassouri; Pierre Szepetowski; Tarik Hammadouche; Antoon Vandenberghe; Colin L Stewart; Djamel Grid; Nicolas Lévy
Journal:  Am J Hum Genet       Date:  2002-01-17       Impact factor: 11.025

6.  A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice.

Authors:  Marina Stavrou; Alexia Kagiava; Sarah G Choudury; Matthew J Jennings; Lindsay M Wallace; Allison M Fowler; Amanda Heslegrave; Jan Richter; Christina Tryfonos; Christina Christodoulou; Henrik Zetterberg; Rita Horvath; Scott Q Harper; Kleopas A Kleopa
Journal:  J Clin Invest       Date:  2022-07-01       Impact factor: 19.456

7.  Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol.

Authors:  Yuri C Martins; Guilherme L Werneck; Leonardo J Carvalho; Beatriz P T Silva; Bruno G Andrade; Tadeu M Souza; Diogo O Souza; Cláudio T Daniel-Ribeiro
Journal:  Malar J       Date:  2010-03-24       Impact factor: 2.979

Review 8.  Understanding Schwann cell-neurone interactions: the key to Charcot-Marie-Tooth disease?

Authors:  Marcel Maier; Philipp Berger; Ueli Suter
Journal:  J Anat       Date:  2002-04       Impact factor: 2.610

9.  Generation and characterization of Rac3 knockout mice.

Authors:  Sara Corbetta; Sara Gualdoni; Chiara Albertinazzi; Simona Paris; Laura Croci; G Giacomo Consalez; Ivan de Curtis
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

10.  Normal cognition in transgenic BRI2-Aβ mice.

Authors:  Jungsu Kim; Paramita Chakrabarty; Amanda Hanna; Amelia March; Dennis W Dickson; David R Borchelt; Todd Golde; Christopher Janus
Journal:  Mol Neurodegener       Date:  2013-05-12       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.